Routine CD4 cell counts worth it vs viral load testing during ART

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.643, 2011-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cotrimoxazole + ART with CD4+ cell testing promising in Ivory Coast

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

CD4 cell counts a plus to guide therapy initiation

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 609, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

CD4+ cell counts show more improvement with early addition of interleukin-2 (IL-2) to HAART

Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

HAART initiation at CD4 cell counts of ≥ 200 cells/mm3 is associated with a decreased risk of anaemia, renal impairment and peripheral neuropathy

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

No CD4 plateau with cART

Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite